NYSE$CHCT
Community Healthcare Trust Incorporated · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Community Healthcare Trust reported its financial results for the three months ended December 31, 2024, including net income, FFO, and AFFO per diluted common share.
Community Healthcare Trust reported net income of approximately $1.8 million for the three months ended December 31, 2024. The company acquired three properties for $8.2 million and disposed of one property and a land parcel for $1.4 million in net proceeds. They also declared a quarterly common stock dividend of $0.4675 per share.
- Net income for the quarter was approximately $1.8 million, or $0.04 per diluted common share.
- FFO per diluted common share was $0.48 and AFFO per diluted common share was $0.55.
- The Company acquired three properties for an aggregate purchase price of approximately $8.2 million, totaling 38,000 square feet and 100% leased.
- The Company disposed of one property in Texas and a land parcel in Georgia, receiving net proceeds of approximately $1.4 million.
Headline financials
Revenue & EPS history
CHCT · Revenue · Quarterly
$29.3M
Revenue by segment
CHCT · $28.7M total across 2 segments · Q3 2023
- Rental Income$27.7M+15.8%96.4%
- Other Operating Interest$1.05M+17.7%3.6%
Forward guidance
The Company has entered into definitive purchase agreements for future acquisitions, including a residential treatment campus and seven other properties, with expected closings extending through 2027.
Tailwinds
- Definitive purchase agreement for a residential treatment campus with an expected purchase price of approximately $9.5 million and an expected return of 9.5%.
- Anticipated closing of the residential treatment campus investment during the first quarter of 2025.
- Seven properties under definitive purchase agreements for an aggregate expected purchase price of approximately $169.5 million.
- Expected returns on these seven investments are approximately 9.1% to 9.75%.
- Anticipated closing on one of the seven properties in the first quarter of 2025, with the remainder throughout 2025, 2026, and 2027.
Headwinds
- No assurance can be provided as to the timing or whether the residential treatment campus transaction will actually close.
- No assurance can be provided as to the timing or whether the seven other property transactions will actually close.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
-0.2%
Avg return
Earnings day
-0.8%
Avg return
5 days after
-2.9%
Avg return
30 days after
47%
20 / 43 earnings
Positive
+9.8%
Q2 2020
Best reaction
-18.9%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.9% | -4.7% | -0.8% | |
| Q4 2025 | -4.7% | -9.4% | -13.8% | |
| Q3 2025 | -0.3% | +1.0% | +7.7% | |
| Q1 2025 | +5.0% | +5.0% | +0.5% | |
| Q4 2024 | -6.3% | -7.0% | -8.0% | |
| Q3 2024 | +6.8% | +3.8% | +6.0% | |
| Q2 2024 | -18.9% | -25.2% | -30.2% | |
| Q1 2024 | -6.2% | -8.9% | -14.2% | |
| Q4 2023 | +0.1% | -1.3% | -4.7% | |
| Q3 2023 | -1.6% | -1.0% | -3.9% | |
| Q2 2023 | +2.7% | +3.4% | -5.8% | |
| Q1 2023 | -0.0% | +1.6% | -9.0% | |
| Q4 2022 | -1.6% | -2.1% | -12.7% | |
| Q3 2022 | +0.9% | +2.0% | +2.7% | |
| Q2 2022 | +0.7% | -0.7% | -9.0% | |
| Q1 2022 | +2.1% | +3.4% | +1.9% | |
| Q4 2021 | +4.2% | +3.2% | -3.4% | |
| Q3 2021 | -3.5% | -2.0% | -10.0% | |
| Q2 2021 | -1.6% | +1.1% | +1.3% | |
| Q1 2021 | -3.9% | -1.7% | -4.9% | |
| Q4 2020 | +0.9% | -0.4% | -1.1% | |
| Q3 2020 | +3.9% | -0.4% | -2.3% | |
| Q2 2020 | +9.8% | +9.9% | +4.6% | |
| Q1 2020 | +7.2% | +5.8% | +4.6% | |
| Q4 2019 | -1.7% | -6.8% | -34.8% | |
| Q3 2019 | -4.9% | -6.6% | -1.8% | |
| Q2 2019 | +3.1% | +3.2% | +2.9% | |
| Q1 2019 | -1.9% | -0.1% | +3.4% | |
| Q4 2018 | -4.7% | -5.9% | +1.3% | |
| Q3 2018 | +1.1% | +1.8% | +5.9% | |
| Q2 2018 | +2.7% | +3.4% | +0.3% | |
| Q1 2018 | +0.2% | -0.8% | +2.2% | |
| Q4 2017 | +7.8% | +5.1% | +10.7% | |
| Q3 2017 | -3.2% | -1.6% | -3.0% | |
| Q2 2017 | -0.2% | +2.1% | +9.4% | |
| Q1 2017 | +2.9% | +1.4% | +2.0% | |
| Q4 2016 | +3.3% | +4.7% | +1.1% | |
| Q3 2016 | -7.3% | -6.4% | +0.4% | |
| Q2 2016 | -0.5% | -2.1% | -7.6% | |
| Q1 2016 | +2.4% | — | — | |
| Q4 2015 | -0.7% | — | — | |
| Q3 2015 | -1.4% | — | — | |
| Q2 2015 | -0.1% | — | — | |
| Q3 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro